Hellgren et al v. Pfizer, Inc et al
Filing
12
ORDER GRANTING 7 STIPULATION. Signed by Judge JEFFREY S. WHITE on 3/1/12. (jjoS, COURT STAFF) (Filed on 3/1/2012)
Case3:12-cv-00735-JSW Document7 Filed02/24/12 Page1 of 4
1
2
3
4
5
6
7
8
WHITE & CASE LLP
BIJAL V. VAKIL (SBN 192878)
bvakil@whitecase.com
5 Palo Alto Square, 9th Floor
3000 El Camino Real
Palo Alto, CA 94306
Telephone: (650) 213-0300
Facsimile:
(650) 213-8158
Counsel for Defendants
PFIZER INC., PFIZER IRELAND
PHARMACEUTICALS, and
WARNER-LAMBERT COMPANY LLC
9
UNITED STATES DISTRICT COURT
10
NORTHERN DISTRICT OF CALIFORNIA
SAN FRANCISCO DIVISION
12
SILICON VALLEY
ATTORNEYS AT LAW
W HITE & C ASE LLP
11
13
SANDRA HELLGREN, an individual, and
BERNARD A. ORSI, an individual,
14
15
16
17
18
19
20
Civil Action No.: 3:12-cv-0735 (NC) (JSW)
Plaintiffs,
STIPULATION AND [PROPOSED]
ORDER
v.
PFIZER, INC., a Delaware Corporation, PFIZER
IRELAND PHARMACEUTICALS, an Irish
partnership, WARNER-LAMBERT COMPANY,
formerly a Delaware Corporation, WARNERLAMBERT COMPANY LLC, a Delaware
limited liability company, RANBAXY, INC., a
Delaware Corporation, and DOES 1-10,
Defendants.
21
22
23
24
25
26
27
28
1
Magistrate Judge Nathanael M. Cousins
Case3:12-cv-00735-JSW Document7 Filed02/24/12 Page2 of 4
1
2
WHEREAS the Notice of Removal of Action from State Court in the above-captioned
action was filed on February 15, 2012; and
3
WHEREAS Plaintiffs Sandra Hellgren and Bernard A. Orsi (collectively, “Plaintiffs”)
4
served Defendants Pfizer Inc., Pfizer Ireland Pharmaceuticals, and Warner-Lambert Company
5
LLC (collectively, “Pfizer”) with a copy of the First Amended Complaint on January 17, 2012;
6
and
7
WHEREAS at least nine other actions have been filed in federal and state courts to date
(“JPML”) to transfer and coordinate these related federal actions, including the above-captioned
11
action, pursuant to 28 U.S.C. § 1407. In re: Lipitor Antitrust Litigation, MDL No. 2332. A
12
SILICON VALLEY
competitors. A petition is currently pending before the Judicial Panel on Multidistrict Litigation
10
ATTORNEYS AT LAW
challenging Pfizer’s allegedly anticompetitive conduct with regard to Lipitor and its generic
9
W HITE & C ASE LLP
8
hearing to consider the transfer and coordination of the actions in MDL No. 2332 is set for March
13
29, 2012; and
14
WHEREAS Plaintiffs and Pfizer have met and conferred on this issue in good faith;
15
IT IS HEREBY STIPULATED AND AGREED, by Plaintiffs and Pfizer, through their
16
respective counsel, that the deadline for Pfizer to answer or otherwise respond to Plaintiffs’ First
17
Amended Complaint shall be extended to fourteen (14) days after the date the JPML issues a
18
ruling or decision regarding transfer and consolidation of actions in MDL No. 2332. The parties
19
reserve their right to discovery in accordance with the Federal Rules of Civil Procedure and/or
20
Civil Local Rules.
21
Respectfully submitted,
22
23
Dated: February 24, 2012
24
25
26
27
/s/ Bijal V. Vakil
Bijal V. Vakil, Esq.
WHITE & CASE LLP
5 Palo Alto Square, 9th Floor
3000 El Camino Real
Palo Alto, California 94306
Tel. 650 213 0300
Fax. 650 213 8158
Counsel for Defendants
-2-
28
PALOALTO 110068
STIPULATION AND PROPOSED ORDER
CASE NO. 3:12-CV-0735 (NC)
Case3:12-cv-00735-JSW Document7 Filed02/24/12 Page3 of 4
PFIZER INC., PFIZER IRELAND
PHARMACEUTICALS, and
WARNER-LAMBERT COMPANY LLC
1
2
3
Dated: February 24, 2012
4
5
6
7
/s/ Lawrence G. Papale
Lawrence G. Papale, Esq.
LAW OFFICE OF LAWRENCE G. PAPALE
1308 Main Street, Suite 117
St. Helena, CA 94574
Tel. (707) 963-1704
Fax. (707) 963-0706
Counsel for Plaintiffs
SANDRA HELLGREN and BERNARD A. ORSI
8
9
10
11
SILICON VALLEY
ATTORNEYS AT LAW
W HITE & C ASE LLP
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
-3PALOALTO 110068
STIPULATION AND PROPOSED ORDER
CASE NO. 3:12-CV-0735 (NC)
Case3:12-cv-00735-JSW Document7 Filed02/24/12 Page4 of 4
1
2
ATTESTATION CLAUSE
I, Bijal V. Vakil, hereby attest in accordance with General Order No. 45.X that Lawrence
3
G. Papale, Counsel for Plaintiffs has provided his concurrence with the electronic filing of the
4
foregoing document entitled STIPULATION AND [PROPOSED] ORDER.
5
Dated: February 24, 2012
WHITE & CASE LLP
6
7
By:
8
/s/ Bijal V. Vakil
Bijal V. Vakil
Counsel for Defendants
PFIZER INC., PFIZER IRELAND
PHARMACEUTICALS, and
WARNER-LAMBERT COMPANY LLC
9
10
11
SILICON VALLEY
ATTORNEYS AT LAW
W HITE & C ASE LLP
12
13
14
15
16
17
18
ORDER
Pursuant to the above Stipulation filed in this action, it is hereby ORDERED that the
time within which Defendants Pfizer Inc., Pfizer Ireland Pharmaceuticals, and WarnerLambert Company LLC may answer or otherwise respond to Plaintiffs’ First Amended
19
Complaint is hereby extended to fourteen (14) days after the date the Judicial Panel on
20
Multidistrict Litigation (“JPML”) issues a ruling or decision regarding the transfer and
21
coordination of actions in In re: Lipitor Antitrust Litigation, MDL No. 2332.
22
23
March 1, 2012
Dated: _____________________
24
__
NATHANAEL M. COUSINS
MAGISTRATE JUDGE JEFFREY S. WHITE
DISTRICT COURT JUDGE
25
26
27
28
-4PALOALTO 110068
STIPULATION AND PROPOSED ORDER
CASE NO. 3:12-CV-0735 (NC)
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
Why Is My Information Online?